Progressive Multiple Sclerosis: Spinal Stem Cell Injections (Phase I Trial)
A phase I trial of intrathecal stem cell-derived neural progenitors in progressive multiple sclerosis, focused on safety and early signals.
View study
Newsroom
31 items, newest first.
A phase I trial of intrathecal stem cell-derived neural progenitors in progressive multiple sclerosis, focused on safety and early signals.
View studyA first-in-human trial of a placenta stem cell patch used in fetal surgery to repair spina bifida. Researchers reported no safety concerns in 6 babies.
View studyA phase 1 trial of placenta-derived stem cells in secondary progressive MS. Researchers reported it was safe, with early signs of improved disability and fatigue.
View studyAn animal study of modified adipose-derived stem cells in autoimmune thyroiditis. Early research, not yet tested in human patients.
View studyA review of mesenchymal stem cell transplantation in systemic lupus erythematosus, exploring why lupus may involve stem cell dysfunction.
View studyA phase I trial of placenta stem cell exosomes for steroid-resistant GVHD after a stem cell transplant. Early results suggest the therapy was well tolerated.
View studyA multicenter clinical study of umbilical cord stem cell transplantation in active, treatment-resistant lupus. See what researchers observed.
View study